La Jolla Pharmaceutical CEO George Tidmarsh's 2018 pay falls 77% to $1.5M

La Jolla Pharmaceutical reports 2018 executive compensation

By ExecPay News

Published: September 18, 2019

La Jolla Pharmaceutical reported fiscal year 2018 executive compensation information on September 18, 2019.
In 2018, four executives at La Jolla Pharmaceutical received on average a compensation package of $948K, a 68% decrease compared to previous year.
Average pay of disclosed executives at La Jolla Pharmaceutical
George F. Tidmarsh, Chief Executive Officer, received $1.5M in total, which decreased by 77% compared to 2017. 55% of Tidmarsh's compensation, or $833K, was in option awards. Tidmarsh also received $75K in non-equity incentive plan, $589K in salary, as well as $12K in other compensation.
Jennifer A. Carver, Chief Operating Officer, received a compensation package of $787K, which decreased by 62% compared to previous year. 51% of the compensation package, or $405K, was in salary.
Lakhmir S. Chawla, Chief Medical Officer, earned $782K in 2018, a 64% decrease compared to previous year.
Dennis M. Mulroy, Chief Financial Officer, received $712K in 2018, which decreases by 65% compared to 2017.

Related executives

George Tidmarsh

La Jolla Pharmaceutical

Chief Executive Officer

Jennifer Carver

La Jolla Pharmaceutical

Chief Operating Officer

Lakhmir Chawla

La Jolla Pharmaceutical

Chief Medical Officer

Dennis Mulroy

La Jolla Pharmaceutical

Chief Financial Officer

You may also like

Source: SEC filing on September 18, 2019.